| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.16 | 3e-06 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.16 | 4e-06 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-05 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.14 | 7e-05 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.16 | 8e-05 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.16 | 9e-05 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |